Inhibiting endothelin receptors with macitentan strengthens the bone protective action of RANKL inhibition and reduces metastatic dissemination in osteosarcoma

Muñoz-Garcia, J., Vargas-Franco, J.W., Royer, B.B.-L. et al. (5 more authors) (2022) Inhibiting endothelin receptors with macitentan strengthens the bone protective action of RANKL inhibition and reduces metastatic dissemination in osteosarcoma. Cancers, 14 (7). 1765. ISSN 2072-6694

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: osteosarcoma; RANKL; endothelin; bone protection; metastases
Dates:
  • Accepted: 29 March 2022
  • Published (online): 30 March 2022
  • Published: 1 April 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 22 Apr 2022 14:59
Last Modified: 22 Apr 2022 14:59
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: https://doi.org/10.3390/cancers14071765

Share / Export

Statistics